title: Activation of TLR2 enhances tight junction barrier in epidermal keratinocytes.
abstract: The epidermis has developed physical and immunological barriers that prevent infiltration of deleterious chemicals and pathogens. As a first step to understanding the relationship between these barriers, we investigated whether TLR2 activation functionally alters tight junctions (TJs) in cultured human keratinocytes. Stimulation with peptidoglycan, a ligand for TLR2, elevated the TJ-associated barrier in the space of 3 h. The increase in TJ-associated barrier function due to peptidoglycan stimulation was suppressed by the knockdown of TLR adaptor MyD88 or the pretreatment with TLR2-neutralizing Ab, indicating that TLR2 activation enhanced TJ-associated barrier. One and 3 h after peptidoglycan stimulation, expression levels of the TJ proteins occludin, claudin-1, claudin-4, and ZO-1 were unchanged. However, immunoprecipitation studies demonstrated that the association of phospho-atypical protein kinase Cζ/ι, crucial for TJ biogenesis, with occludin was increased. Significantly, inhibition of atypical protein kinase Cζ/ι activity completely blocked the immediate elevation of the TJ-associated barrier. Finally, peptidoglycan was applied to the stratum corneum surface of a human skin equivalent, and the TJ barrier was evaluated. In the space of 3 h after the stimulation, the amount of intercellular tracer in the stratum corneum incubated from the dermal side was reduced, indicating that the TJ barrier is strengthened via TLR2 activation. Taken together, our findings indicated that infiltration of pathogens into the epidermis immediately enhanced TJ function via TLR2 signaling. Furthermore, the dynamically controlled TJs in skin are considered fundamental in preventing further invasion of pathogens and maintaining cutaneous barrier homeostasis.
authors.affiliation: Innovative Beauty Science Laboratory, Kanebo Cosmetics, Inc., Kanagawa, 250-0002, Japan.
authors.forename: Takuo
authors.initials: T
authors.lastname: Yuki
authors.forename: Hiroyuki
authors.initials: H
authors.lastname: Yoshida
authors.forename: Yumiko
authors.initials: Y
authors.lastname: Akazawa
authors.forename: Aya
authors.initials: A
authors.lastname: Komiya
authors.forename: Yoshinori
authors.initials: Y
authors.lastname: Sugiyama
authors.forename: Shintaro
authors.initials: S
authors.lastname: Inoue
mesh_terms: D002478:Cells, Cultured; D006801:Humans; D015151:Immunoblotting; D047468:Immunoprecipitation; D015603:Keratinocytes / Q000276:immunology / Q000378:metabolism*; D008565:Membrane Proteins / Q000276:immunology / Q000378:metabolism; D008856:Microscopy, Fluorescence; D062793:Occludin; D011493:Protein Kinase C / Q000276:immunology / Q000378:metabolism; D015398:Signal Transduction / Q000276:immunology; D012867:Skin / Q000276:immunology / Q000378:metabolism; D019108:Tight Junctions / Q000276:immunology / Q000378:metabolism*; D051195:Toll-Like Receptor 2 / Q000276:immunology / Q000378:metabolism*
chemical_list: D008565:Membrane Proteins; C568985:OCLN protein, human; D062793:Occludin; C495342:TLR2 protein, human; D051195:Toll-Like Receptor 2; D011493:Protein Kinase C